Navigation Links
Websites Are Judged In Less Than A Second

People who surf the web do not take more than a couple of seconds to decide whether the website is worth it or not, according to recent scientific findings. The decision is often taken in less than a second. //

‘My colleagues believed it would be impossible to really see anything in less than 500 milliseconds,’ Nature quoted Gitte Lindgaard of Carleton University in Ottawa, who has published the research in the journal Behavior and Information Technology, as saying about their findings that impressions were made in the first 50 milliseconds of viewing.

These findings, the researchers said, should be seriously taken note of by web companies hoping to drive traffic on their sites.

‘Unless the first impression is favorable, visitors will be out of your site before they even know that you might be offering more than your competitors,’ Lindgaard said. And according to Marc Caudron of London web-design agency Pod, the findings make a user's first impression even more critical.

‘You'll get a list of sites, click the top one, and then either say 'I've engaged' and give it a few more seconds, or just go back to Google,’ the journal quoted him, as saying.

And he suggests that to use these findings to their benefit, site owners should ensure that the amount of graphics on the page should be strictly limited, perhaps to a single eye-catching image, and make sure that web pages load quickly, otherwise customers might not stick around long enough to make that coveted first impression.

Edited (NI)
'"/>




Page: 1

Related medicine news :

1. Websites That Offer Panacea for Eating Disorders may Be Dangerous
2. Second hope for men with erectile dysfunction
3. Second SARS suspect fuels worry in India
4. The Harmful Effects Of Secondhand Smoke
5. Second Hand Exposure To Smoke In Childhood Can Cause Respiratory Problems Later
6. HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A Second Epidemic
7. Women With Breast Cancer At Risk For Developing Second Cancer
8. Stroke Destroys Nearly 32, 000 Neurons In Just A Second!
9. Can Second Hand Smoke Cause Cancer?
10. Second Hand Smoke Does No Harm
11. Healthy Kidney Removed From Patient, Second Surgery Needed

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Websites Are Judged Less Than Second

(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...
(Date:11/25/2009)...f a collaboration between UCLA engineers and physi...0 million Americans who suffer from peripheral art...the arteries, peripheral arterial disease, or PAD,... arteries reduce blood flow to the limbs. The cond...e, heart attack and stroke, and its progression ca...
(Date:11/25/2009)...o draw definite conclusions, experts say, , ...iabetic patients with blocked coronary arteries, t...e year whether patients undergo bypass surgery or ...ort. , Bypass surgery has been the standard tre...disease. However, less invasive approaches such as...
(Date:11/25/2009)...reatment clinics to resume Monday, Nov. 30 , ... 2009 -- Centegra Health System is continuing to o... four Centegra Primary Care (CPC) vaccination clin... The clinics are at CPC sites in Huntley, Woodstoc...llows: ,   From 4:30 to 7:30 p.m. Tues...
(Date:11/25/2009)...mptoms, study finds , , WEDNESDAY, Nov....are among the potential problems faced by long-ter...with cisplatin-based chemotherapy, a new study has...n treated for unilateral testicular cancer between... conducted from 1998 to 2002. , The researchers...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...lity drugs to get pregnant can breathe a sigh of r...he popular medications used to increase the number...e do not increase the risk of ovarian cancer. // ...ad difficulty conceiving took fertility drugs and ...
...ated that Men who suffer from constipation are mor...in disease Parkinson's some have suggested that th...f the gut long before it manifests itself elsewher...high risk of developing the disease in the future....
...ng under polluted, hazy skies move away to communi...ore quickly, according to a study by researchers a...dicine researchers followed more than 100 children...affected annual rates of lung function growth, the...
...euths found that the absence of a certain protein ... water levels.Reported in the New England journal ...ey works.// The protein aquaporin-1has a d...ency of the protein have a limited ability to reab...
... bagged the registration, production and marketing...he Centre for Biotechnology in the Jawaharlal Nehr...e would be in the market in 3-4 months. The Compan...t to make any projections on the business the vacc...
...covered that frequent sexual intercourse can actua...attack.Middle aged men can have sex as many times/...f having a stroke, according to research. P...between sex and strokes. The team based its findin...
Other Medicine News:Health News:Particulate matter affects lung development 2
(Date:11/25/2009)...Call/--Hologic,Inc.(HologicortheCompany)(Nasdaq: H...remiumdiagnostics,medicalimagingsystemsandsurgical...n,isusingtheannualmeetingoftheRadiologicalSocietyo...ber29throughDecember3,2009tohighlightournewSecurVi...stationsoftware. ,, TheHologicSecurViewworkstat...
(Date:11/25/2009)...dsResearchGroup,Inc.releasedWave1ofits LaunchTren...yndicatedmarketresearchprojecttrackingthelaunchofC...oughthefirstsixmonthsofavailability.Eachwaveofther...rmatologistsandqualitativeinformationfromasubsetof...ouse,typicalpatienttypes,productperceptions,promot...
(Date:11/25/2009)...e/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmeric...hatitreceivedtheEnvironmentalResponsibilityandSust...mmit,sponsoredbytheCaliforniaManufacturersandTechn...ssociation(IEA)andtheChemicalIndustryCouncilofCali...sawardavailablefromallthreeorganizationsandgainssu...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 1AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 2AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 3AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 4AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 5AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 6AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 7AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 8AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 9AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 10AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 11AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 12AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 13AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 14AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 15AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 16AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 17AMERIGROUP Reports Q3 Net Income of 2422 5 Million or 240 43 per Diluted Share 60386 18AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 1AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 2AcelRx Announces Successful Completion of End of Phase 2 Meeting on ARX 01 Sufentanil NanoTab PCA System for Post Operative Pain Management 60384 3First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 1First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 2First Choice Health Services Inc Named to 2009 HomeCare Elite as a Top Home Health Care Provider 60382 3
...reported in,the journal Pharmacogenomics suggests ...ic Factor gene (CNTF) may affect response to,antip...Pharmaceuticals,Inc., included patients with acute... with Fiapta(TM) (iloperidone), a novel atypical,a... FDA, or placebo.,Patients were also studied for a...
...r Blood-Derived Stem Cells and Strong In...NEW YORK, Feb. 28 NeoStem, Inc. (Amex: NBS ),whi...ssing and long-term,storage of adult stem cells fo...ositive research conclusions and industry trends p...sociation and at the recent Third Annual,Stem Cell...
Other Medicine Technology:Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 2Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 3NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit 2NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit 3NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: